nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyzine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.187	0.293	CbGbCtD
Hydroxyzine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.173	0.271	CbGbCtD
Hydroxyzine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.142	0.222	CbGbCtD
Hydroxyzine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.136	0.213	CbGbCtD
Hydroxyzine—Drug eruption—Glimepiride—type 2 diabetes mellitus	0.012	0.0393	CcSEcCtD
Hydroxyzine—Drug eruption—Glyburide—type 2 diabetes mellitus	0.00992	0.0324	CcSEcCtD
Hydroxyzine—Tremor—Nateglinide—type 2 diabetes mellitus	0.00453	0.0148	CcSEcCtD
Hydroxyzine—Drowsiness—Glipizide—type 2 diabetes mellitus	0.00443	0.0145	CcSEcCtD
Hydroxyzine—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.00414	0.0135	CcSEcCtD
Hydroxyzine—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.00373	0.0122	CcSEcCtD
Hydroxyzine—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00372	0.0122	CcSEcCtD
Hydroxyzine—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00339	0.0111	CcSEcCtD
Hydroxyzine—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00339	0.0111	CcSEcCtD
Hydroxyzine—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00335	0.011	CcSEcCtD
Hydroxyzine—Hallucination—Bromocriptine—type 2 diabetes mellitus	0.00333	0.0109	CcSEcCtD
Hydroxyzine—Rash—Miglitol—type 2 diabetes mellitus	0.00329	0.0107	CcSEcCtD
Hydroxyzine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00328	0.0107	CcSEcCtD
Hydroxyzine—Urticaria—Acarbose—type 2 diabetes mellitus	0.00325	0.0106	CcSEcCtD
Hydroxyzine—Tremor—Glipizide—type 2 diabetes mellitus	0.00325	0.0106	CcSEcCtD
Hydroxyzine—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00314	0.0103	CcSEcCtD
Hydroxyzine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00311	0.0102	CcSEcCtD
Hydroxyzine—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.00306	0.01	CcSEcCtD
Hydroxyzine—Tremor—Glimepiride—type 2 diabetes mellitus	0.00303	0.00991	CcSEcCtD
Hydroxyzine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00302	0.00987	CcSEcCtD
Hydroxyzine—Rash—Tolbutamide—type 2 diabetes mellitus	0.00295	0.00966	CcSEcCtD
Hydroxyzine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00294	0.0096	CcSEcCtD
Hydroxyzine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00291	0.00952	CcSEcCtD
Hydroxyzine—Convulsion—Glimepiride—type 2 diabetes mellitus	0.0028	0.00917	CcSEcCtD
Hydroxyzine—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00272	0.00888	CcSEcCtD
Hydroxyzine—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00269	0.00881	CcSEcCtD
Hydroxyzine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00269	0.00879	CcSEcCtD
Hydroxyzine—Rash—Tolazamide—type 2 diabetes mellitus	0.00269	0.00879	CcSEcCtD
Hydroxyzine—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.00268	0.00878	CcSEcCtD
Hydroxyzine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00267	0.00874	CcSEcCtD
Hydroxyzine—Headache—Tolazamide—type 2 diabetes mellitus	0.00267	0.00874	CcSEcCtD
Hydroxyzine—Rash—Linagliptin—type 2 diabetes mellitus	0.00266	0.0087	CcSEcCtD
Hydroxyzine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00266	0.00869	CcSEcCtD
Hydroxyzine—Headache—Linagliptin—type 2 diabetes mellitus	0.00264	0.00865	CcSEcCtD
Hydroxyzine—Rash—Acarbose—type 2 diabetes mellitus	0.00258	0.00845	CcSEcCtD
Hydroxyzine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00258	0.00844	CcSEcCtD
Hydroxyzine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00257	0.0084	CcSEcCtD
Hydroxyzine—Drowsiness—Metformin—type 2 diabetes mellitus	0.00256	0.00839	CcSEcCtD
Hydroxyzine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00253	0.00827	CcSEcCtD
Hydroxyzine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00252	0.00824	CcSEcCtD
Hydroxyzine—Somnolence—Glipizide—type 2 diabetes mellitus	0.00251	0.00822	CcSEcCtD
Hydroxyzine—Tremor—Glyburide—type 2 diabetes mellitus	0.0025	0.00817	CcSEcCtD
Hydroxyzine—Rash—Nateglinide—type 2 diabetes mellitus	0.00249	0.00815	CcSEcCtD
Hydroxyzine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00249	0.00814	CcSEcCtD
Hydroxyzine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00247	0.00807	CcSEcCtD
Hydroxyzine—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00243	0.00795	CcSEcCtD
Hydroxyzine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00235	0.00767	CcSEcCtD
Hydroxyzine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00234	0.00765	CcSEcCtD
Hydroxyzine—Convulsion—Glyburide—type 2 diabetes mellitus	0.00231	0.00756	CcSEcCtD
Hydroxyzine—Urticaria—Glipizide—type 2 diabetes mellitus	0.00225	0.00735	CcSEcCtD
Hydroxyzine—Tremor—Gliclazide—type 2 diabetes mellitus	0.00224	0.00734	CcSEcCtD
Hydroxyzine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00223	0.00728	CcSEcCtD
Hydroxyzine—Rash—Repaglinide—type 2 diabetes mellitus	0.00216	0.00705	CcSEcCtD
Hydroxyzine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00215	0.00704	CcSEcCtD
Hydroxyzine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00215	0.00704	CcSEcCtD
Hydroxyzine—Headache—Repaglinide—type 2 diabetes mellitus	0.00214	0.007	CcSEcCtD
Hydroxyzine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00212	0.00692	CcSEcCtD
Hydroxyzine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.0021	0.00686	CcSEcCtD
Hydroxyzine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00209	0.00684	CcSEcCtD
Hydroxyzine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00208	0.00682	CcSEcCtD
Hydroxyzine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00208	0.00679	CcSEcCtD
Hydroxyzine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00204	0.00666	CcSEcCtD
Hydroxyzine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00204	0.00666	CcSEcCtD
Hydroxyzine—Hypotension—Glyburide—type 2 diabetes mellitus	0.00203	0.00665	CcSEcCtD
Hydroxyzine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00202	0.00662	CcSEcCtD
Hydroxyzine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.002	0.00653	CcSEcCtD
Hydroxyzine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00199	0.00652	CcSEcCtD
Hydroxyzine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00194	0.00636	CcSEcCtD
Hydroxyzine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00194	0.00634	CcSEcCtD
Hydroxyzine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00189	0.00619	CcSEcCtD
Hydroxyzine—Convulsion—Orlistat—type 2 diabetes mellitus	0.00188	0.00616	CcSEcCtD
Hydroxyzine—Flunarizine—CALM1—type 2 diabetes mellitus	0.00188	0.139	CrCbGaD
Hydroxyzine—Tremor—Metformin—type 2 diabetes mellitus	0.00188	0.00614	CcSEcCtD
Hydroxyzine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00183	0.00599	CcSEcCtD
Hydroxyzine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00183	0.00597	CcSEcCtD
Hydroxyzine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00181	0.00592	CcSEcCtD
Hydroxyzine—Rash—Glipizide—type 2 diabetes mellitus	0.00178	0.00583	CcSEcCtD
Hydroxyzine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00178	0.00583	CcSEcCtD
Hydroxyzine—Headache—Glipizide—type 2 diabetes mellitus	0.00177	0.0058	CcSEcCtD
Hydroxyzine—Tremor—Irbesartan—type 2 diabetes mellitus	0.00177	0.00579	CcSEcCtD
Hydroxyzine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00174	0.00568	CcSEcCtD
Hydroxyzine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00173	0.00566	CcSEcCtD
Hydroxyzine—Headache—Pioglitazone—type 2 diabetes mellitus	0.0017	0.00555	CcSEcCtD
Hydroxyzine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00168	0.00549	CcSEcCtD
Hydroxyzine—Tremor—Losartan—type 2 diabetes mellitus	0.00167	0.00545	CcSEcCtD
Hydroxyzine—Rash—Glimepiride—type 2 diabetes mellitus	0.00166	0.00544	CcSEcCtD
Hydroxyzine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00166	0.00544	CcSEcCtD
Hydroxyzine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00166	0.00543	CcSEcCtD
Hydroxyzine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00166	0.00542	CcSEcCtD
Hydroxyzine—Headache—Glimepiride—type 2 diabetes mellitus	0.00165	0.00541	CcSEcCtD
Hydroxyzine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00165	0.00539	CcSEcCtD
Hydroxyzine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0016	0.00525	CcSEcCtD
Hydroxyzine—Somnolence—Valsartan—type 2 diabetes mellitus	0.0016	0.00522	CcSEcCtD
Hydroxyzine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00157	0.00515	CcSEcCtD
Hydroxyzine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00155	0.00508	CcSEcCtD
Hydroxyzine—Hypotension—Metformin—type 2 diabetes mellitus	0.00153	0.005	CcSEcCtD
Hydroxyzine—Rash—Bromocriptine—type 2 diabetes mellitus	0.0015	0.00491	CcSEcCtD
Hydroxyzine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.0015	0.00491	CcSEcCtD
Hydroxyzine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00149	0.00488	CcSEcCtD
Hydroxyzine—Dry mouth—Losartan—type 2 diabetes mellitus	0.00148	0.00485	CcSEcCtD
Hydroxyzine—Somnolence—Metformin—type 2 diabetes mellitus	0.00145	0.00476	CcSEcCtD
Hydroxyzine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00144	0.00472	CcSEcCtD
Hydroxyzine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00144	0.00471	CcSEcCtD
Hydroxyzine—Tremor—Ramipril—type 2 diabetes mellitus	0.00143	0.00468	CcSEcCtD
Hydroxyzine—Urticaria—Valsartan—type 2 diabetes mellitus	0.00143	0.00467	CcSEcCtD
Hydroxyzine—Urticaria—Orlistat—type 2 diabetes mellitus	0.00141	0.00461	CcSEcCtD
Hydroxyzine—Rash—Glyburide—type 2 diabetes mellitus	0.00137	0.00449	CcSEcCtD
Hydroxyzine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00137	0.00449	CcSEcCtD
Hydroxyzine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00137	0.00448	CcSEcCtD
Hydroxyzine—Headache—Glyburide—type 2 diabetes mellitus	0.00136	0.00446	CcSEcCtD
Hydroxyzine—Hypotension—Losartan—type 2 diabetes mellitus	0.00136	0.00444	CcSEcCtD
Hydroxyzine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00132	0.00433	CcSEcCtD
Hydroxyzine—Convulsion—Ramipril—type 2 diabetes mellitus	0.00132	0.00432	CcSEcCtD
Hydroxyzine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00131	0.00428	CcSEcCtD
Hydroxyzine—Urticaria—Metformin—type 2 diabetes mellitus	0.0013	0.00425	CcSEcCtD
Hydroxyzine—Somnolence—Losartan—type 2 diabetes mellitus	0.00129	0.00422	CcSEcCtD
Hydroxyzine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00127	0.00416	CcSEcCtD
Hydroxyzine—Rash—Gliclazide—type 2 diabetes mellitus	0.00123	0.00403	CcSEcCtD
Hydroxyzine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00123	0.00403	CcSEcCtD
Hydroxyzine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00123	0.00401	CcSEcCtD
Hydroxyzine—Headache—Gliclazide—type 2 diabetes mellitus	0.00122	0.00401	CcSEcCtD
Hydroxyzine—Hypotension—Ramipril—type 2 diabetes mellitus	0.00116	0.00381	CcSEcCtD
Hydroxyzine—Urticaria—Losartan—type 2 diabetes mellitus	0.00115	0.00377	CcSEcCtD
Hydroxyzine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00114	0.00372	CcSEcCtD
Hydroxyzine—Rash—Valsartan—type 2 diabetes mellitus	0.00113	0.0037	CcSEcCtD
Hydroxyzine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00113	0.0037	CcSEcCtD
Hydroxyzine—Headache—Valsartan—type 2 diabetes mellitus	0.00113	0.00368	CcSEcCtD
Hydroxyzine—Rash—Orlistat—type 2 diabetes mellitus	0.00112	0.00366	CcSEcCtD
Hydroxyzine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00112	0.00366	CcSEcCtD
Hydroxyzine—Headache—Orlistat—type 2 diabetes mellitus	0.00111	0.00364	CcSEcCtD
Hydroxyzine—Somnolence—Ramipril—type 2 diabetes mellitus	0.00111	0.00362	CcSEcCtD
Hydroxyzine—Meclizine—CYP1A2—type 2 diabetes mellitus	0.0011	0.0813	CrCbGaD
Hydroxyzine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00107	0.0035	CcSEcCtD
Hydroxyzine—Rash—Metformin—type 2 diabetes mellitus	0.00103	0.00337	CcSEcCtD
Hydroxyzine—Dermatitis—Metformin—type 2 diabetes mellitus	0.00103	0.00337	CcSEcCtD
Hydroxyzine—Headache—Metformin—type 2 diabetes mellitus	0.00102	0.00335	CcSEcCtD
Hydroxyzine—Perphenazine—CALM1—type 2 diabetes mellitus	0.00102	0.0757	CrCbGaD
Hydroxyzine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000989	0.00324	CcSEcCtD
Hydroxyzine—Rash—Irbesartan—type 2 diabetes mellitus	0.000973	0.00318	CcSEcCtD
Hydroxyzine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000972	0.00318	CcSEcCtD
Hydroxyzine—Headache—Irbesartan—type 2 diabetes mellitus	0.000967	0.00316	CcSEcCtD
Hydroxyzine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000918	0.003	CcSEcCtD
Hydroxyzine—Rash—Losartan—type 2 diabetes mellitus	0.000916	0.003	CcSEcCtD
Hydroxyzine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000915	0.00299	CcSEcCtD
Hydroxyzine—Headache—Losartan—type 2 diabetes mellitus	0.00091	0.00298	CcSEcCtD
Hydroxyzine—Rash—Ramipril—type 2 diabetes mellitus	0.000785	0.00257	CcSEcCtD
Hydroxyzine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000785	0.00257	CcSEcCtD
Hydroxyzine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	0.000784	0.0581	CrCbGaD
Hydroxyzine—Headache—Ramipril—type 2 diabetes mellitus	0.00078	0.00255	CcSEcCtD
Hydroxyzine—Nefazodone—ADRA2A—type 2 diabetes mellitus	0.000779	0.0578	CrCbGaD
Hydroxyzine—Trazodone—ADRA2A—type 2 diabetes mellitus	0.000721	0.0535	CrCbGaD
Hydroxyzine—Nefazodone—HTR2C—type 2 diabetes mellitus	0.000717	0.0532	CrCbGaD
Hydroxyzine—Clemastine—CYP3A4—type 2 diabetes mellitus	0.000682	0.0506	CrCbGaD
Hydroxyzine—Trazodone—HTR2C—type 2 diabetes mellitus	0.000664	0.0492	CrCbGaD
Hydroxyzine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000594	0.0441	CrCbGaD
Hydroxyzine—Flunarizine—CYP1A2—type 2 diabetes mellitus	0.00059	0.0438	CrCbGaD
Hydroxyzine—Cinnarizine—CYP1A2—type 2 diabetes mellitus	0.000467	0.0346	CrCbGaD
Hydroxyzine—Perphenazine—ADRA2A—type 2 diabetes mellitus	0.000462	0.0343	CrCbGaD
Hydroxyzine—Quetiapine—ADRA2A—type 2 diabetes mellitus	0.000453	0.0336	CrCbGaD
Hydroxyzine—Perphenazine—HTR2C—type 2 diabetes mellitus	0.000425	0.0315	CrCbGaD
Hydroxyzine—Quetiapine—HTR2C—type 2 diabetes mellitus	0.000417	0.0309	CrCbGaD
Hydroxyzine—Nefazodone—CYP3A4—type 2 diabetes mellitus	0.000358	0.0266	CrCbGaD
Hydroxyzine—Trazodone—CYP3A4—type 2 diabetes mellitus	0.000332	0.0246	CrCbGaD
Hydroxyzine—Perphenazine—CYP1A2—type 2 diabetes mellitus	0.000321	0.0238	CrCbGaD
Hydroxyzine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	0.000297	0.022	CrCbGaD
Hydroxyzine—Perphenazine—CYP3A4—type 2 diabetes mellitus	0.000212	0.0158	CrCbGaD
Hydroxyzine—Quetiapine—CYP3A4—type 2 diabetes mellitus	0.000208	0.0154	CrCbGaD
Hydroxyzine—HRH1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	9.28e-05	0.00213	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	9.24e-05	0.00212	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	9.24e-05	0.00212	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	9.03e-05	0.00207	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	8.98e-05	0.00206	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	8.96e-05	0.00205	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	8.91e-05	0.00204	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	8.83e-05	0.00202	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	8.8e-05	0.00202	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	8.69e-05	0.00199	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	8.69e-05	0.00199	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	8.54e-05	0.00196	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	8.45e-05	0.00194	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GIP—type 2 diabetes mellitus	8.14e-05	0.00186	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTM1—type 2 diabetes mellitus	8.1e-05	0.00186	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GCG—type 2 diabetes mellitus	8.04e-05	0.00184	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	7.99e-05	0.00183	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	7.86e-05	0.0018	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	7.64e-05	0.00175	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	7.62e-05	0.00175	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	7.46e-05	0.00171	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	7.36e-05	0.00169	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	7.09e-05	0.00162	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	7.03e-05	0.00161	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	6.93e-05	0.00159	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	6.92e-05	0.00159	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	6.87e-05	0.00157	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	6.84e-05	0.00157	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	6.73e-05	0.00154	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	6.68e-05	0.00153	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	6.56e-05	0.0015	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	6.51e-05	0.00149	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	6.45e-05	0.00148	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	6.18e-05	0.00142	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	6.11e-05	0.0014	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	5.96e-05	0.00136	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	5.93e-05	0.00136	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	5.86e-05	0.00134	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	5.84e-05	0.00134	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	5.82e-05	0.00133	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	5.81e-05	0.00133	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	5.68e-05	0.0013	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	5.67e-05	0.0013	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	5.64e-05	0.00129	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	5.46e-05	0.00125	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	5.46e-05	0.00125	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	5.4e-05	0.00124	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	5.4e-05	0.00124	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	5.4e-05	0.00124	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	5.4e-05	0.00124	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	5.28e-05	0.00121	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	5.24e-05	0.0012	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	5.15e-05	0.00118	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	5.12e-05	0.00117	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	5.12e-05	0.00117	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	5.12e-05	0.00117	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	5.1e-05	0.00117	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	4.99e-05	0.00114	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	4.99e-05	0.00114	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	4.97e-05	0.00114	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	4.91e-05	0.00113	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	4.9e-05	0.00112	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	4.88e-05	0.00112	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	4.81e-05	0.0011	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	4.76e-05	0.00109	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	4.63e-05	0.00106	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	4.57e-05	0.00105	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	4.56e-05	0.00104	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	4.55e-05	0.00104	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	4.53e-05	0.00104	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	4.51e-05	0.00103	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	4.51e-05	0.00103	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	4.51e-05	0.00103	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	4.47e-05	0.00102	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	4.46e-05	0.00102	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	4.45e-05	0.00102	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	4.36e-05	0.001	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	4.35e-05	0.000997	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.35e-05	0.000997	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	4.35e-05	0.000997	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	4.35e-05	0.000997	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	4.35e-05	0.000997	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	4.25e-05	0.000973	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	4.22e-05	0.000966	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	4.13e-05	0.000946	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	4.09e-05	0.000937	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	4.06e-05	0.000931	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	3.98e-05	0.000912	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	3.98e-05	0.000912	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	3.95e-05	0.000905	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	3.92e-05	0.000898	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	3.88e-05	0.000889	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	3.87e-05	0.000886	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	3.7e-05	0.000848	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	3.7e-05	0.000848	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	3.7e-05	0.000848	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	3.68e-05	0.000842	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	3.64e-05	0.000835	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	3.61e-05	0.000827	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	3.61e-05	0.000827	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	3.56e-05	0.000815	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	3.55e-05	0.000813	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	3.55e-05	0.000813	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.52e-05	0.000806	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.52e-05	0.000806	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.51e-05	0.000804	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.51e-05	0.000804	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	3.5e-05	0.000803	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.49e-05	0.0008	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.46e-05	0.000793	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.42e-05	0.000783	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	3.42e-05	0.000783	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	3.36e-05	0.000769	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.34e-05	0.000765	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	3.3e-05	0.000756	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	3.3e-05	0.000756	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.3e-05	0.000756	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.29e-05	0.000753	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.21e-05	0.000736	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.17e-05	0.000727	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.14e-05	0.000719	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.12e-05	0.000714	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	3.1e-05	0.000711	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	3.1e-05	0.00071	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.05e-05	0.000699	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.04e-05	0.000697	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.04e-05	0.000696	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.03e-05	0.000693	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.98e-05	0.000684	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	2.92e-05	0.000668	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	2.9e-05	0.000665	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.9e-05	0.000664	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.82e-05	0.000646	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.81e-05	0.000645	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.81e-05	0.000645	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	2.8e-05	0.000643	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.8e-05	0.000643	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	2.8e-05	0.000643	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.8e-05	0.000643	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.77e-05	0.000635	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.74e-05	0.000627	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.72e-05	0.000624	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.72e-05	0.000624	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.69e-05	0.000616	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.68e-05	0.000614	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.67e-05	0.000611	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.67e-05	0.000611	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.63e-05	0.000604	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.56e-05	0.000587	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.5e-05	0.000573	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.48e-05	0.000568	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.47e-05	0.000566	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	2.44e-05	0.000559	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.44e-05	0.000559	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.4e-05	0.00055	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.39e-05	0.000548	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.33e-05	0.000535	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.29e-05	0.000524	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.29e-05	0.000524	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.28e-05	0.000523	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.24e-05	0.000514	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.24e-05	0.000514	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.24e-05	0.000513	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.23e-05	0.000511	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.23e-05	0.000511	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.23e-05	0.000511	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.21e-05	0.000507	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.17e-05	0.000498	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.15e-05	0.000493	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.12e-05	0.000486	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.1e-05	0.000482	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.07e-05	0.000475	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.07e-05	0.000475	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.06e-05	0.000473	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.06e-05	0.000471	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.03e-05	0.000466	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	2e-05	0.000459	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2e-05	0.000458	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2e-05	0.000458	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2e-05	0.000458	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2e-05	0.000457	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.97e-05	0.000452	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.96e-05	0.000449	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.94e-05	0.000445	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.91e-05	0.000438	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.9e-05	0.000436	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.87e-05	0.000429	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.83e-05	0.000419	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.81e-05	0.000414	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.81e-05	0.000414	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.8e-05	0.000411	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.76e-05	0.000404	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.76e-05	0.000404	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.73e-05	0.000397	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.73e-05	0.000397	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	1.72e-05	0.000395	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.64e-05	0.000377	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.64e-05	0.000376	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.64e-05	0.000375	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.61e-05	0.000369	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.6e-05	0.000368	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.6e-05	0.000368	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.59e-05	0.000363	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.51e-05	0.000347	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.49e-05	0.000342	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.49e-05	0.000342	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.49e-05	0.000341	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.47e-05	0.000336	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.43e-05	0.000328	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.42e-05	0.000326	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.39e-05	0.000317	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	1.37e-05	0.000314	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.36e-05	0.000312	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.35e-05	0.000309	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-05	0.000305	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.33e-05	0.000304	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.33e-05	0.000304	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.32e-05	0.000304	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.32e-05	0.000302	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.29e-05	0.000296	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.28e-05	0.000292	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.26e-05	0.000288	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.22e-05	0.000281	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.2e-05	0.000275	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.2e-05	0.000275	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-05	0.000275	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.16e-05	0.000267	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.14e-05	0.000262	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.14e-05	0.000261	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.13e-05	0.000259	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-05	0.000258	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.03e-05	0.000236	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.02e-05	0.000234	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.01e-05	0.000232	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	9.93e-06	0.000227	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	9.74e-06	0.000223	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.64e-06	0.000221	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.54e-06	0.000219	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.35e-06	0.000214	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	8.93e-06	0.000205	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.89e-06	0.000204	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.66e-06	0.000198	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.54e-06	0.000196	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.54e-06	0.000196	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.95e-06	0.000182	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	7.81e-06	0.000179	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.79e-06	0.000179	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.99e-06	0.000137	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.52e-06	0.000127	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.92e-06	8.99e-05	CbGpPWpGaD
